WorldCat Linked Data Explorer

Turtle N-Triple JSON-LD RDF/XML HTML Contact Us Home

http://worldcat.org/entity/work/id/1070375899

Challenges to value-enhancing innovation in health care delivery commonalities and contrasts with innovation in drugs and devices

Open All Close All

type

about

contributor

description

http://schema.org/description

  • ""Limiting the growth of health care costs while improving population health is perhaps the most important and difficult challenge facing U.S. health policymakers. The role of innovation in advancing these social goals is controversial, with many seeing innovation as a major cause of cost growth and many others viewing innovation as crucial for improving the quality of care and health outcomes. The authors argue that mitigating the tension between improving health and controlling costs requires more-nuanced perspectives on innovation. More specifically, they argue that policymakers should carefully distinguish between innovative activities that are worth their social costs and activities that are not worth their social costs and try to encourage the former and discourage the latter. The paper considers innovation in drugs, devices, and methods of delivering health care, with particular attention to delivery"
  • ""Limiting the growth of health care costs while improving population health is perhaps the most important and difficult challenge facing U.S. health policymakers. The role of innovation in advancing these social goals is controversial, with many seeing innovation as a major cause of cost growth and many others viewing innovation as crucial for improving the quality of care and health outcomes. The authors argue that mitigating the tension between improving health and controlling costs requires more-nuanced perspectives on innovation. More specifically, they argue that policymakers should carefully distinguish between innovative activities that are worth their social costs and activities that are not worth their social costs and try to encourage the former and discourage the latter. The paper considers innovation in drugs, devices, and methods of delivering health care, with particular attention to delivery."--Provided by publisher."
  • ""Limiting the growth of health care costs while improving population health is perhaps the most important and difficult challenge facing U.S. health policymakers. The role of innovation in advancing these social goals is controversial, with many seeing innovation as a major cause of cost growth and many others viewing innovation as crucial for improving the quality of care and health outcomes. The authors argue that mitigating the tension between improving health and controlling costs requires more-nuanced perspectives on innovation. More specifically, they argue that policymakers should carefully distinguish between innovative activities that are worth their social costs and activities that are not worth their social costs and try to encourage the former and discourage the latter. The paper considers innovation in drugs, devices, and methods of delivering health care, with particular attention to delivery.""

name

http://schema.org/name

  • "Challenges to value-enhancing innovation in health care delivery commonalities and contrasts with innovation in drugs and devices"
  • "Challenges to value-enhancing innovation in health care delivery : commonalities and contrasts with innovation in drugs and devices"

workExample